-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Intellipharmaceutics International Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2023.
- Intellipharmaceutics International Inc. Net Income (Loss) Attributable to Parent for the quarter ending August 31, 2023 was -$1.89M, a 548% decline year-over-year.
- Intellipharmaceutics International Inc. Net Income (Loss) Attributable to Parent for the twelve months ending August 31, 2023 was -$3.18M, a 19.9% increase year-over-year.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.89M, a 43.8% increase from 2021.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.15M, a 51.7% decline from 2020.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$3.39M, a 58.1% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)